Assembly Biosciences (ASMB) FCF Margin Growth (1y) (2018 - 2026)
Assembly Biosciences (ASMB) FCF Margin Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -89.00 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -1,183.00 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 869.00 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -7.76 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 811.00 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 769.00 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 19,111.00 |
| 10 | Assembly Biosciences | 670.88 Mn | 350.52 Mn | - | 5,752.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5,752.00 |
| Mar 31, 2026 | -2,043.00 |
| Dec 31, 2025 | 3,900.00 |
| Sep 30, 2025 | 8,205.00 |
| Jun 30, 2025 | 2,649.00 |
| Mar 31, 2025 | 6,884.00 |
| Dec 31, 2024 | -104,431.00 |
| Sep 30, 2021 | -39,154.00 |
| Dec 31, 2020 | -200,580.00 |
| Sep 30, 2020 | 55,061.00 |
| Jun 30, 2020 | 61,878.00 |
| Mar 31, 2020 | -4,461.00 |
| Dec 31, 2019 | 2,255.00 |
| Sep 30, 2019 | -12,485.00 |
| Jun 30, 2019 | -18,150.00 |
| Mar 31, 2019 | -13,798.00 |
| Dec 31, 2018 | -14,785.00 |
| Sep 30, 2018 | 4,072.00 |
| Jun 30, 2018 | 2,231.00 |
| Mar 31, 2018 | -554,369.00 |